Compare MGM Resorts International (MGM) vs Philip Morris International Inc. (PM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MGM Resorts International vs Philip Morris International Inc. — how do they compare? MGM Resorts International trades at $30.16 (market cap $7.55B), while Philip Morris International Inc. trades at $199.75 (market cap $300.33B). The key difference: Philip Morris International Inc. is far larger — about 39.8× MGM Resorts International's market cap, and Philip Morris International Inc. pays the higher dividend (3.32%). Which is the better fit depends on your goals — on Pluang, investors hold MGM Resorts International for 91 Days and Philip Morris International Inc. for 85 Days on average.
| MGM | PM | |
|---|---|---|
Market Cap | $7.55B | $300.33B |
Volume | 5,398,410 | 3,935,700 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $50.69 | $200.50 |
52-Week Low | $30.00 | $144.33 |
Typical Hold Time | 91 Days | 85 Days |
Enterprise Value | $34.85B | $343.44B |
Dividend Yield | 0.03% | 3.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MGM Resorts International (MGM) trades at $30.01, down 1.74% over 24 hours amid recent deal volatility. The stock is technically bearish with key support at $30, while fundamentals show revenue growth to $17.54B in 2025 but declining net margins to 2.4%. Recent news highlights a collapsed $48.30-per-share acquisition offer from Barry Diller's People Inc., contributing to negative sentiment and a 17% stock decline in 2026.
MGM's investment outlook is mixed: analyst consensus is bullish with a $49.85 price target, but risks include earnings volatility, high debt, and integration challenges from potential M&A. The stock offers value with a low P/S of 0.45, yet investors face headwinds from competitive pressures and macroeconomic sensitivity in the gaming sector.
Philip Morris International (PM) trades at $200.5, up 5.3% over 24 hours, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The company shows robust fundamentals with 2025 revenue of $40.65B and net income of $11.35B, supported by a 67.48% gross margin. Recent news highlights expansion of smoke-free products like ZYN and IQOS, now over 40% of revenue, driving growth amid industry shifts.
Outlook is positive with analyst consensus at Buy (68%) and a $212.17 price target, though elevated P/E of 26.46 and regulatory risks in tobacco remain concerns. Earnings growth and smoke-free product adoption are key catalysts, but investors should monitor debt levels and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
